[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cue Biopharma Inc (CUE)

Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cue Biopharma Inc 40 GUEST STREET BOSTON MA 02135 USA

www.cuebiopharma.com Employees: 29 P: 617-949-2680

Sector:

Medical

Description:

Cue Biopharma, Inc. is an immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. Cue Biopharma, Inc. is headquartered in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 91,595
Enterprise Value, $K 64,455
Shares Outstanding, K 4,046
Float, K 3,457
% Float 85.44%
Short Interest, K 289
Short Float 7.13%
Days to Cover 1.00
Short Volume Ratio 0.44
% of Insider Shareholders 14.56%
% of Institutional Shareholders 35.04%

Financials:

Annual Sales, $ 27,470 K
Annual Net Income, $ -26,600 K
Last Quarter Sales, $ 5,690 K
Last Quarter Net Income, $ -5,180 K
EBIT, $ -19,610 K
EBITDA, $ -18,830 K

Growth:

1-Year Return 17.08%
3-Year Return -81.64%
5-Year Return -94.32%
5-Year Revenue Growth 772.06%
5-Year Earnings Growth 82.05%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.08 on 05/14/26
Next Earnings Date 08/11/26
Earnings Per Share ttm -5.58
EPS Growth vs. Prev Qtr -459.64%
EPS Growth vs. Prev Year 78.84%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 04/24/26

CUE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -98.30%
Return-on-Assets % -53.69%
Profit Margin % -96.83%
Debt/Equity 0.00
Price/Sales 3.01
Price/Cash Flow N/A
Price/Book 3.08
Book Value/Share 6.63
Interest Coverage -71.50
60-Month Beta 2.37
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.